GSK Pharmaceuticals - 4QFY2013 Result Review - Angel Broking

GSK Pharmaceuticals, posted results lower than expectations on the sales front. The net sales, came in at Rs. 632cr during 1QCY2013, a growth of 1.5% yoy. This was against a expectations of Rs. 734cr. Consequently, the OPM's came in at 25.5% V/s expectations of 30.4%, a contraction of 5.9%. On account of which the net profit came in at Rs. 170cr, a decline of 8.9% during the last corresponding period.

We recommend a neutral on the stock.

Source : Equity Bulls

Keywords